Immunoclin (Immunoclin) Gross-Profit-to-Asset % : 0.10% (As of Oct. 2014)

Immunoclin Gross-Profit-to-Asset % Chart

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Gross-Profit-to-Asset %	Get a 7-Day Free Trial									-	-	-	-	0.10

Competitive Comparison of Immunoclin's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Immunoclin's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunoclin's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Immunoclin's Gross-Profit-to-Asset % falls into.

Immunoclin Gross-Profit-to-Asset % Calculation

Immunoclin's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jan. 2014 is calculated as:

Immunoclin's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2014 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Oct. 2014) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Immunoclin Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Immunoclin's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description